JP Morgan Maintains Overweight on Stryker, Lowers Price Target to $350

Benzinga · 2d ago
JP Morgan analyst Robbie Marcus maintains Stryker (NYSE:SYK) with a Overweight and lowers the price target from $400 to $350.